Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a government-operating-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference13%

- Check34 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release; the Back to Top link has been removed as a minor navigation change.SummaryDifference0.8%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.8%

- Check63 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference9%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.